Recombinant human granulocyte– colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial

Autor: Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D, Ahmed, A, Bass, C, Benderatik, R, Bhattacharya, R, Cheong, Y, Dawood, F, Granne, I, Gupta, P, Horne, A, Manda, P, Mohiyiddeen, L, Moore, J, Quenby, S, Rai, R, Shillito, J, Stewart, J, Truchanowicz, E, Dwyer, L, Small, R, Sharpe, L, Smith, A, Coomarasamy, A, Grp, RESPONSE Study

Publikováno v: Human Reproduction (Oxford, England)
Eapen, A, Joing, M, Kwon, P, Tong, J, Maneta, E, De Santo, C, Mussai, F, Lissauer, D, Carter, D 2019, ' Recombinant human granulocyte-colony stimulating factor in women with unexplained recurrent pregnancy losses : A randomized clinical trial ', Human Reproduction, vol. 34, no. 3, pp. 424-432 . https://doi.org/10.1093/humrep/dey393
HUMAN REPRODUCTION

Study question Does administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) in the first trimester improve pregnancy outcomes, among women with a history of unexplained recurrent pregnancy loss? Summary answer rhG-CSF admi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28be5dbc70a779e2f322e57cd04257a
http://europepmc.org/articles/PMC6389865

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prepulse reactivity in prepulse inhibition

Autor: Truchanowicz, Ewa G.

Prepulse inhibition (PPI) is a popular paradigm in sensorimotor gating research. In healthy individuals the weak lead stimulus (i.e., the prepulse) presentation results in a reduction in the startle probe (pulse) elicited response. The motor response

Externí odkaz: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.678328

CardioPulse: New perspectives for stroke prevention in atrial fibrillation.

Autor: Truchanowicz E, Kirchhof P

Publikováno v: European heart journal [Eur Heart J] 2016 Feb 14; Vol. 37 (7), pp. 583-4.